Sonnhag C, Karlsson E
Eur J Clin Pharmacol. 1979 Jun 12;15(5):311-7. doi: 10.1007/BF00558433.
Ten patients with persistent ventricular arrhythmia were studied in a comparison of the antiarrhythmic efficacy of N-acetylprocainamide (NAPA) and procainamide (PA). Each patient performed three exercise tests for 40 min., on different days, with submaximal and fixed work loads. During the first exercise test no drug was administered. During the following two tests PA and NAPA, respectively, were administered by intravenous infusion. The electrocardiogram was continously recorded and was analyzed minute by minute. Blood samples for determination of plasma drug concentration were frequently collected. Exercise alone did not significantly change the incidence of arrhythmia. Both PA and NAPA showed a similar and significant antiarrhythmic effect. A blood pressure fall was seen in two patients after administration of each drug. No other adverse reaction was observed.
对10例持续性室性心律失常患者进行了N - 乙酰普鲁卡因胺(NAPA)和普鲁卡因胺(PA)抗心律失常疗效的比较研究。每位患者在不同日期进行了3次40分钟的运动试验,运动负荷为次最大且固定。在第一次运动试验期间未给药。在接下来的两次试验中,分别通过静脉输注给予PA和NAPA。连续记录心电图并每分钟进行分析。频繁采集血样以测定血浆药物浓度。单独运动并未显著改变心律失常的发生率。PA和NAPA均显示出相似且显著的抗心律失常作用。每种药物给药后,有两名患者出现血压下降。未观察到其他不良反应。